Evidence map›Paper›PMID 7637019›Full record

ArticleJournal of virology1995

Persistence of attenuated rev genes in a human immunodeficiency virus type 1-infected asymptomatic individual.

A K Iversen, E G Shpaer, A G Rodrigo, M S Hirsch, B D Walker, H W Sheppard, T C Merigan, J I Mullins

Open access · bronzeAbstract readCase ReportsComparative Study
In one paragraph

Article in Journal of virology, 1995. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 51 papers.

0numbers the graph read from it
0cells of the map it votes in
51citing papers in PubMed
2.0field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

51 citing papers in PubMed, 101 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Viral factors in non-progression.Frontiers in immunology · 2013
    Review
  15. Article
  16. Article
  17. Review
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

A K IversenDepartment of Microbiology and Immunology, Stanford University School of Medicine, California 94305-5402, USA.
E G Shpaer
A G Rodrigo
M S Hirsch
B D Walker
H W Sheppard
T C Merigan
J I Mullins
Stanford University · US

Funding

EVOLUTION OF HIV ENV ANTIGENS AND IMMUNE RESPONSER01AI032885 · NIAID · UNIVERSITY OF WASHINGTON · PI MULLINS, JAMES IVAN · 1993 to 1997
–
VIRUS AND IMMUNE RESPONSE CHANGES IN AIDS PROGRESSIONR01AI034783 · NIAID · PUBLIC HEALTH FOUNDATION ENTERPRISES · PI SHEPPARD, HAYNES W · 1994 to 1998
–
NIAID NIH HHS AI32885NIAID NIH HHS AI34783NIAID NIH HHS AI82515
6 · The paper itself

Abstract

With the goal of examining the functional diversity of human immunodeficiency virus type 1 (HIV-1) env genes within the peripheral blood mononuclear cells of an asymptomatic individual, we substituted four complete env genes into the replication-competent NL4-3 provirus. Despite encoding full-length open reading frames for gp120 and gp41 and the second coding exon of tat and rev, each chimera was replication defective. Site-directed mutagenesis of codon 78 in the Rev activation domain (from a hitherto unique Ile to the subtype B consensus Leu) partially restored infectivity for two of three chimeras tested. Similarly, mutagenesis of rev codon 78 of NL4-3 from Leu to Ile partially attenuated this virus. Ile-78 was found in all 13 clones examined from samples taken from this asymptomatic subject 4.5 years after infection, including 9 from peripheral blood mononuclear cells and 4 from a virus isolate, as well as 4 additional clones each from peripheral blood mononuclear cells sampled 37 and 51 months later. We next examined conservation of the Rev activation domain within and among long-term survivors (LTS) and patients with AIDS, as well as T-cell-line-adapted strains of HIV-1. Putative attenuating mutations were found in a minority of sequences from all five LTS and two of four patients with AIDS. Of the 11 T-cell-line-adapted viruses examined, none had these changes. Among and within LTS virus population had marginally higher levels of diversity in Rev than in Env; patients with AIDS had similar levels of diversity in the two reading frames; and T-cell-line-adapted viruses had higher levels of diversity in Env. These results are consistent with the hypothesis that asymptomatic individuals harbor attenuated variants of HIV-1 which correlate with and contribute to their lack of disease progression.

Indexed as

Genes, revAcquired Immunodeficiency SyndromeAmino Acid SequenceAnimalsBase Sequencebeta-GalactosidaseCell LineCells, CulturedChimeraChlorocebus aethiopsDNA PrimersDNA, ViralExonsGene Expression Regulation, ViralGene Products, revGenome, Viralbeta-GalactosidaseDNA PrimersDNA, ViralGene Products, revHIV Envelope Protein gp41Interleukin-2OligodeoxyribonucleotidesRecombinant Proteinsrev Gene Products, Human Immunodeficiency Virus

Identifiers

PMID7637019
PMCPMC189435
OpenAlexW2157112409

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.